U
PPH icon

UBS’s VanEck Pharmaceutical ETF PPH Stock Holding History

UBS’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$2.48M Buy
38,993
+14,648
+60% +$907K ﹤0.01% 2703
2014
Q2 		$1.51M Buy
24,345
+4,960
+26% +$295K ﹤0.01% 3161
2014
Q1 		$1.13M Buy
19,385
+10,145
+110% +$574K ﹤0.01% 3370
2013
Q4 		$490K Sell
9,240
-320
-3% -$16.2K ﹤0.01% 4371
2013
Q3 		$457K Sell
9,560
-1,562
-14% -$74.1K ﹤0.01% 4237
2013
Q2 		$506K Buy
+11,122
New +$514K ﹤0.01% 4089

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
MIM
Macroview Investment Management Bethesda, Maryland $162M AUM 22.52% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

UBS's PPH Position: Q3 2014 in Review

UBS increased its VanEck Pharmaceutical ETF (PPH) stake by 60% in Q3 2014, buying an estimated $907K and bringing the position to 38,993 shares worth $2.48M. The position accounts for ﹤0.01% of the portfolio, ranked #2703.

UBS first reported a position in PPH in Q2 2013 and has held it in 6 quarters since. 49 funds tracked by Wall St. Rank hold PPH as of Q3 2014.

  • UBS held 38,993 shares of VanEck Pharmaceutical ETF worth $2.48M as of Q3 2014.
  • UBS bought 14,648 VanEck Pharmaceutical ETF shares in Q3 2014, an estimated $907K.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2703 holding.
  • UBS first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and has held it in 6 quarters since.
  • 49 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.